Literature DB >> 15848153

Survivin expression is regulated by an epigenetic mechanism for DMBA-induced hamster buccal-pouch squamous-cell carcinomas.

Y-K Chen1, S-S Hsue, L-M Lin.   

Abstract

Apoptosis, also known as programmed cell death, is regulated by a number of inhibitory or stimulatory factors. In addition to the pro- and anti-apoptotic Bcl-2 family proteins, there is also a family of inhibitors of apoptosis protein (IAP). Survivin, a member of this IAP family, is selectively upregulated in most tumours. The objective of the present study was, therefore, to investigate the protein and mRNA expression of survivin, as well as the methylation status of the CpG sites in exon 1 of the survivin gene for 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal-pouch squamous-cell carcinomas. Immunohistochemical analysis for protein expression, RT-PCR for mRNA expression, and a PCR-based methylation assay were performed on 26 samples of hamster buccal pouches. The total study population was assigned into either one experimental group (15-week DMBA treatment; n=13) or two control groups (untreated: n=6; mineral-oil treated n=7). Cytoplasmic staining of survivin protein and mRNA were detected in all of the hamster buccal-pouch tissue specimens treated with DMBA, whereas neither survivin protein nor survivin mRNA were noted for all of the untreated and mineral oil-treated hamster buccal-pouch tissue specimens. Furthermore, all the untreated and mineral-oil treated samples had a survivin-methylated allele, whereas the DMBA-treated cancerous tissues showed no evidence of survivin methylation. The results suggest that survivin may play an important role in DMBA-induced hamster buccal-pouch carcinomas, and that the gene expression may be modulated by an epigenetic mechanism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15848153     DOI: 10.1016/j.archoralbio.2004.11.011

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  8 in total

Review 1.  Epigenetic mechanisms in oral carcinogenesis.

Authors:  Jacqueline A Gasche; Ajay Goel
Journal:  Future Oncol       Date:  2012-11       Impact factor: 3.404

Review 2.  Clinico-pathologic relevance of Survivin splice variant expression in cancer.

Authors:  Rosalia de Necochea-Campion; Chien-Shing Chen; Saied Mirshahidi; Frank D Howard; Nathan R Wall
Journal:  Cancer Lett       Date:  2013-06-18       Impact factor: 8.679

Review 3.  Transcriptional and post-transcriptional controls of survivin in cancer cells: novel approaches for cancer treatment.

Authors:  M Zhang; J Yang; F Li
Journal:  J Exp Clin Cancer Res       Date:  2006-09

4.  Expression of inhibitors of apoptosis family protein in 7,12-dimethylbenz[a]anthracene-induced hamster buccal-pouch squamous-cell carcinogenesis is associated with mutant p53 accumulation and epigenetic changes.

Authors:  Shui-Sang Hsue; Wen-Chen Wang; Yuk-Kwan Chen; Li-Min Lin
Journal:  Int J Exp Pathol       Date:  2008-04-17       Impact factor: 1.925

Review 5.  Survivin splice variants and their diagnostic significance.

Authors:  Nand K Sah; Chandrabhan Seniya
Journal:  Tumour Biol       Date:  2015-08-06

Review 6.  Current Insights into Oral Cancer Epigenetics.

Authors:  Alexandra Iulia Irimie; Cristina Ciocan; Diana Gulei; Nikolay Mehterov; Atanas G Atanasov; Diana Dudea; Ioana Berindan-Neagoe
Journal:  Int J Mol Sci       Date:  2018-02-27       Impact factor: 5.923

Review 7.  Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma.

Authors:  Zakir Khan; Abdul Arif Khan; Hariom Yadav; Godavarthi B K S Prasad; Prakash Singh Bisen
Journal:  Cell Mol Biol Lett       Date:  2017-04-05       Impact factor: 5.787

8.  The prognostic significance of survivin expression in patients with HNSCC: a systematic review and meta-analysis.

Authors:  Liu-Qing Zhou; Yao Hu; Hong-Jun Xiao
Journal:  BMC Cancer       Date:  2021-04-17       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.